XSESC2PU
Market cap1.75bUSD
Dec 20, Last price
3.63SGD
1D
-0.55%
1Q
-11.25%
Jan 2017
53.81%
IPO
192.74%
Name
Parkway Life Real Estate Investment Trust
Chart & Performance
Profile
Parkway Life Real Estate Investment Trust (PLife REIT) is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 147,467 13.46% | 129,972 7.68% | 120,705 -0.15% | |||||||
Cost of revenue | 24,574 | 24,195 | 24,805 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 122,893 | 105,777 | 95,900 | |||||||
NOPBT Margin | 83.34% | 81.38% | 79.45% | |||||||
Operating Taxes | 7,803 | 7,081 | 8,874 | |||||||
Tax Rate | 6.35% | 6.69% | 9.25% | |||||||
NOPAT | 115,090 | 98,696 | 87,026 | |||||||
Net income | 100,465 144.23% | 41,136 -87.61% | 331,878 280.49% | |||||||
Dividends | (88,391) | (64,312) | (85,184) | |||||||
Dividend yield | 3.98% | 2.83% | 2.74% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 53,559 | 56,650 | 94,733 | |||||||
Long-term debt | 776,996 | 797,337 | 735,386 | |||||||
Deferred revenue | 1,506 | 1,732 | 1,860 | |||||||
Other long-term liabilities | 20,461 | 17,754 | 19,360 | |||||||
Net debt | 802,056 | 779,549 | 788,431 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 99,001 | 94,632 | 89,862 | |||||||
CAPEX | (31,036) | (63,891) | (11,692) | |||||||
Cash from investing activities | (49,557) | (125,184) | (74,988) | |||||||
Cash from financing activities | (67,919) | 47,753 | (9,981) | |||||||
FCF | 63,056 | 185,215 | (219,578) | |||||||
Balance | ||||||||||
Cash | 28,499 | 40,010 | 25,793 | |||||||
Long term investments | 34,428 | 15,895 | ||||||||
Excess cash | 21,126 | 67,939 | 35,653 | |||||||
Stockholders' equity | 585,258 | 3,021,460 | 3,046,851 | |||||||
Invested Capital | 2,243,869 | 2,213,921 | 2,248,281 | |||||||
ROIC | 5.16% | 4.42% | 4.12% | |||||||
ROCE | 5.34% | 4.56% | 4.13% | |||||||
EV | ||||||||||
Common stock shares outstanding | 605,002 | 605,002 | 605,002 | |||||||
Price | 3.67 -2.39% | 3.76 -26.71% | 5.13 32.22% | |||||||
Market cap | 2,220,357 -2.39% | 2,274,808 -26.71% | 3,103,660 32.22% | |||||||
EV | 3,022,413 | 3,866,235 | 4,694,305 | |||||||
EBITDA | 122,893 | 105,777 | 95,922 | |||||||
EV/EBITDA | 24.59 | 36.55 | 48.94 | |||||||
Interest | 12,931 | 6,104 | 4,170 | |||||||
Interest/NOPBT | 10.52% | 5.77% | 4.35% |